PDB Short entry for 1Q6J HEADER HYDROLASE 13-AUG-03 1Q6J TITLE THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH TITLE 2 COMPOUND 2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN; COMPND 5 SYNONYM: PROTEIN-TYROSINE PHOSPHATASE 1B, PTP-1B; COMPND 6 EC: 3.1.3.48; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PTPN1 OR PTP1B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFLAG-2 KEYWDS PHOSPHATASE, SECONDARY BINDING SITE, SELECTIVITY, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR G.SCAPIN,S.B.PATEL,J.W.BECKER,Q.WANG,C.DESPONTS,D.WADDLETON,K.SKOREY, AUTHOR 2 W.CROMLISH,C.BAYLY,M.THERIEN,J.Y.GAUTHIER,C.S.LI,C.K.LAU, AUTHOR 3 C.RAMACHANDRAN,B.P.KENNEDY,E.ASANTE-APPIAH REVDAT 5 16-AUG-23 1Q6J 1 REMARK SEQADV ATOM REVDAT 4 11-OCT-17 1Q6J 1 REMARK REVDAT 3 24-FEB-09 1Q6J 1 VERSN REVDAT 2 14-OCT-03 1Q6J 1 JRNL REVDAT 1 30-SEP-03 1Q6J 0 JRNL AUTH G.SCAPIN,S.B.PATEL,J.W.BECKER,Q.WANG,C.DESPONTS,D.WADDLETON, JRNL AUTH 2 K.SKOREY,W.CROMLISH,C.BAYLY,M.THERIEN,J.Y.GAUTHIER,C.S.LI, JRNL AUTH 3 C.K.LAU,C.RAMACHANDRAN,B.P.KENNEDY,E.ASANTE-APPIAH JRNL TITL THE STRUCTURAL BASIS FOR THE SELECTIVITY OF BENZOTRIAZOLE JRNL TITL 2 INHIBITORS OF PTP1B JRNL REF BIOCHEMISTRY V. 42 11451 2003 JRNL REFN ISSN 0006-2960 JRNL PMID 14516196 JRNL DOI 10.1021/BI035098J REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.2 REMARK 3 NUMBER OF REFLECTIONS : 25399 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.215 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.500 REMARK 3 FREE R VALUE TEST SET COUNT : 1776 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 27840 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.30 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2270 REMARK 3 BIN R VALUE (WORKING SET) : 0.2780 REMARK 3 BIN FREE R VALUE : 0.3290 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 179 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2349 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 44 REMARK 3 SOLVENT ATOMS : 116 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.92200 REMARK 3 B22 (A**2) : 2.92200 REMARK 3 B33 (A**2) : -5.84300 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM SIGMAA (A) : 0.25 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.28 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 BOND ANGLES (DEGREES) : 1.490 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.14 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.970 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.220 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.650 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.100 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.450 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : MASK REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 33.63 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1Q6J COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-AUG-03. REMARK 100 THE DEPOSITION ID IS D_1000019978. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-JUN-99 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NA REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : BRUKER REMARK 200 INTENSITY-INTEGRATION SOFTWARE : X-GEN REMARK 200 DATA SCALING SOFTWARE : X-GEN REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26132 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 37.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.8 REMARK 200 DATA REDUNDANCY : 8.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08400 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.34 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.0 REMARK 200 DATA REDUNDANCY IN SHELL : 9.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.40400 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: PDB ENTRY 1PTY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.14 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, MGCL2, HEPES, PH 7.00, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 69.84650 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 43.41900 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 43.41900 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 34.92325 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 43.41900 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 43.41900 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 104.76975 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 43.41900 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 43.41900 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 34.92325 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 43.41900 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 43.41900 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 104.76975 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 69.84650 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 456 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 471 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1001 REMARK 465 ASP A 1002 REMARK 465 TYR A 1003 REMARK 465 LYS A 1004 REMARK 465 ASP A 1005 REMARK 465 ASP A 1006 REMARK 465 ASP A 1007 REMARK 465 ASP A 1008 REMARK 465 SER A 286 REMARK 465 VAL A 287 REMARK 465 GLN A 288 REMARK 465 ASP A 289 REMARK 465 GLN A 290 REMARK 465 TRP A 291 REMARK 465 LYS A 292 REMARK 465 GLU A 293 REMARK 465 LEU A 294 REMARK 465 SER A 295 REMARK 465 HIS A 296 REMARK 465 GLU A 297 REMARK 465 ASP A 298 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A1009 CG CD CE NZ REMARK 470 LEU A1010 CG CD1 CD2 REMARK 470 MET A 1 CG SD CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 62 -84.52 -67.23 REMARK 500 ASP A 63 -77.80 -44.44 REMARK 500 LYS A 120 -164.68 -117.41 REMARK 500 CYS A 121 131.30 -178.24 REMARK 500 CYS A 215 -131.13 -141.33 REMARK 500 ILE A 219 -39.21 -135.19 REMARK 500 ILE A 261 106.94 77.88 REMARK 500 ASP A 284 42.91 -92.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 335 A 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1Q6M RELATED DB: PDB REMARK 900 SAME PROTEIN IN COMPLEX WITH {[2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-2-(3, REMARK 900 4-DIFLUOROPHENYL)PROPANE-1,3-DIYL]BIS[4,1- REMARK 900 PHENYLENE(DIFLUOROMETHYLENE)]}BISPHOSPHONIC ACID REMARK 900 RELATED ID: 1Q6N RELATED DB: PDB REMARK 900 SAME PROTEIN IN COMPLEX WITH [{4-[(4E)-2-(1,3-BENZOTHIAZOL-2-YL)-2- REMARK 900 (1H-1,2,3-BENZOTRIAZOL-1-YL)-5-PHENYLPENT-4-EN-1-YL]PHENYL} REMARK 900 (DIFLUORO)METHYL]PHOSPHONIC ACID REMARK 900 RELATED ID: 1Q6P RELATED DB: PDB REMARK 900 SAME PROTEIN IN COMPLEX WITH [{4-[(4E)-2-(1,3-BENZOTHIAZOL-2-YL)-2- REMARK 900 (1H-1,2,3-BENZOTRIAZOL-1-YL)-5-PHENYLPENT-4-EN-1-YL]PHENYL} REMARK 900 (DIFLUORO)METHYL]PHOSPHONIC ACID REMARK 900 RELATED ID: 1Q6S RELATED DB: PDB REMARK 900 SAME PROTEIN IN COMPLEX WITH {6-[4-(2-(1H-1,2,3-BENZOTRIAZOL-1-YL)- REMARK 900 3-{4-[DIFLUORO(PHOSPHONO)METHYL]PHENYL}-2-PHENYLPROPYL)PHENYL]-2- REMARK 900 METHYLQUINOLIN-8-YL}PHOSPHONIC ACID REMARK 900 RELATED ID: 1Q6T RELATED DB: PDB REMARK 900 SAME PROTEIN IN COMPLEX WITH [6-[4-(2-(1H-1,2,3-BENZOTRIAZOL-1-YL)- REMARK 900 3-{4-[DIFLUORO(PHOSPHONO)METHYL]PHENYL}-2-PHENYLPROPYL)PHENYL]-2-(1- REMARK 900 METHOXY-3-METHYLBUTYL)QUINOLIN-8-YL]PHOSPHONIC ACID DBREF 1Q6J A 1 298 UNP P18031 PTN1_HUMAN 1 298 SEQADV 1Q6J MET A 1001 UNP P18031 CLONING ARTIFACT SEQADV 1Q6J ASP A 1002 UNP P18031 CLONING ARTIFACT SEQADV 1Q6J TYR A 1003 UNP P18031 CLONING ARTIFACT SEQADV 1Q6J LYS A 1004 UNP P18031 CLONING ARTIFACT SEQADV 1Q6J ASP A 1005 UNP P18031 CLONING ARTIFACT SEQADV 1Q6J ASP A 1006 UNP P18031 CLONING ARTIFACT SEQADV 1Q6J ASP A 1007 UNP P18031 CLONING ARTIFACT SEQADV 1Q6J ASP A 1008 UNP P18031 CLONING ARTIFACT SEQADV 1Q6J LYS A 1009 UNP P18031 CLONING ARTIFACT SEQADV 1Q6J LEU A 1010 UNP P18031 CLONING ARTIFACT SEQADV 1Q6J GLU A 1011 UNP P18031 CLONING ARTIFACT SEQADV 1Q6J PHE A 1012 UNP P18031 CLONING ARTIFACT SEQRES 1 A 310 MET ASP TYR LYS ASP ASP ASP ASP LYS LEU GLU PHE MET SEQRES 2 A 310 GLU MET GLU LYS GLU PHE GLU GLN ILE ASP LYS SER GLY SEQRES 3 A 310 SER TRP ALA ALA ILE TYR GLN ASP ILE ARG HIS GLU ALA SEQRES 4 A 310 SER ASP PHE PRO CYS ARG VAL ALA LYS LEU PRO LYS ASN SEQRES 5 A 310 LYS ASN ARG ASN ARG TYR ARG ASP VAL SER PRO PHE ASP SEQRES 6 A 310 HIS SER ARG ILE LYS LEU HIS GLN GLU ASP ASN ASP TYR SEQRES 7 A 310 ILE ASN ALA SER LEU ILE LYS MET GLU GLU ALA GLN ARG SEQRES 8 A 310 SER TYR ILE LEU THR GLN GLY PRO LEU PRO ASN THR CYS SEQRES 9 A 310 GLY HIS PHE TRP GLU MET VAL TRP GLU GLN LYS SER ARG SEQRES 10 A 310 GLY VAL VAL MET LEU ASN ARG VAL MET GLU LYS GLY SER SEQRES 11 A 310 LEU LYS CYS ALA GLN TYR TRP PRO GLN LYS GLU GLU LYS SEQRES 12 A 310 GLU MET ILE PHE GLU ASP THR ASN LEU LYS LEU THR LEU SEQRES 13 A 310 ILE SER GLU ASP ILE LYS SER TYR TYR THR VAL ARG GLN SEQRES 14 A 310 LEU GLU LEU GLU ASN LEU THR THR GLN GLU THR ARG GLU SEQRES 15 A 310 ILE LEU HIS PHE HIS TYR THR THR TRP PRO ASP PHE GLY SEQRES 16 A 310 VAL PRO GLU SER PRO ALA SER PHE LEU ASN PHE LEU PHE SEQRES 17 A 310 LYS VAL ARG GLU SER GLY SER LEU SER PRO GLU HIS GLY SEQRES 18 A 310 PRO VAL VAL VAL HIS CYS SER ALA GLY ILE GLY ARG SER SEQRES 19 A 310 GLY THR PHE CYS LEU ALA ASP THR CYS LEU LEU LEU MET SEQRES 20 A 310 ASP LYS ARG LYS ASP PRO SER SER VAL ASP ILE LYS LYS SEQRES 21 A 310 VAL LEU LEU GLU MET ARG LYS PHE ARG MET GLY LEU ILE SEQRES 22 A 310 GLN THR ALA ASP GLN LEU ARG PHE SER TYR LEU ALA VAL SEQRES 23 A 310 ILE GLU GLY ALA LYS PHE ILE MET GLY ASP SER SER VAL SEQRES 24 A 310 GLN ASP GLN TRP LYS GLU LEU SER HIS GLU ASP HET 335 A 301 44 HETNAM 335 [4-(2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-3-{4- HETNAM 2 335 [DIFLUORO(PHOSPHONO)METHYL]PHENYL}-2-PHENYLPROPYL) HETNAM 3 335 PHENYL](DIFLUORO)METHYLPHOSPHONIC ACID FORMUL 2 335 C29 H25 F4 N3 O6 P2 FORMUL 3 HOH *116(H2 O) HELIX 1 1 LYS A 1009 SER A 13 1 17 HELIX 2 2 SER A 15 HIS A 25 1 11 HELIX 3 3 LEU A 37 ASN A 44 5 8 HELIX 4 4 THR A 91 GLN A 102 1 12 HELIX 5 5 SER A 187 SER A 201 1 15 HELIX 6 6 GLY A 220 ARG A 238 1 19 HELIX 7 7 ASP A 240 VAL A 244 5 5 HELIX 8 8 ASP A 245 LYS A 255 1 11 HELIX 9 9 THR A 263 MET A 282 1 20 SHEET 1 A 9 ARG A 56 LYS A 58 0 SHEET 2 A 9 TYR A 66 MET A 74 -1 O ALA A 69 N ILE A 57 SHEET 3 A 9 ARG A 79 THR A 84 -1 O TYR A 81 N ILE A 72 SHEET 4 A 9 VAL A 211 HIS A 214 1 O VAL A 213 N ILE A 82 SHEET 5 A 9 GLY A 106 MET A 109 1 N VAL A 108 O VAL A 212 SHEET 6 A 9 THR A 168 TYR A 176 1 O PHE A 174 N VAL A 107 SHEET 7 A 9 TYR A 153 ASN A 162 -1 N THR A 154 O HIS A 175 SHEET 8 A 9 LEU A 140 ILE A 149 -1 N ASP A 148 O VAL A 155 SHEET 9 A 9 MET A 133 PHE A 135 -1 N PHE A 135 O LEU A 140 SITE 1 AC1 30 ALA A 18 ASP A 22 HIS A 25 GLU A 26 SITE 2 AC1 30 TYR A 46 ARG A 47 ASP A 48 SER A 118 SITE 3 AC1 30 LEU A 119 ASP A 181 PHE A 182 CYS A 215 SITE 4 AC1 30 SER A 216 ALA A 217 GLY A 218 ILE A 219 SITE 5 AC1 30 GLY A 220 ARG A 221 MET A 258 GLY A 259 SITE 6 AC1 30 GLN A 262 HOH A 407 HOH A 418 HOH A 430 SITE 7 AC1 30 HOH A 437 HOH A 442 HOH A 449 HOH A 464 SITE 8 AC1 30 HOH A 475 HOH A 507 CRYST1 86.838 86.838 139.693 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011516 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011516 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007159 0.00000